Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 6.17
-5.08 %
$ 329 M
Market Cap
-8.57
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
29.25%
EBIT
Estimate
6.71%
Net Income
Estimate
42.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alpha Teknova, Inc.
TKNO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart TKNO
EBIT FORECAST
EBIT Forecast Chart TKNO
NET INCOME FORECAST
Net Income Chart TKNO